PharmaIN Unveils Phase 1b Data on PHIN-214 for Liver Cirrhosis at AASLD 2024
January 3, 2025
PharmaIN Corporation, a clinical-stage biopharmaceutical company dedicated to developing innovative subcutaneous peptide therapies, introduced interim results from its ongoing Phase 1b clinical trial of PHIN-214